{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:58:59Z","timestamp":1791244739289,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jiac.2025.102713","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T15:10:13Z","timestamp":1744989013000},"page":"102713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Post-vaccinal seronegative autoimmune encephalitis following recombinant zoster vaccination in two immunocompetent patients"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-0623","authenticated-orcid":false,"given":"Tariq A.","family":"Madani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer A.","family":"Khoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-6734","authenticated-orcid":false,"given":"Ahmad R.","family":"Abuzinadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-5517","authenticated-orcid":false,"given":"Ghada M.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-9527","authenticated-orcid":false,"given":"Alaa A.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad I.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman T.","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7892","key":"10.1016\/j.jiac.2025.102713_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"304","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jiac.2025.102713_bib2","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102713_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.virol.2012.10.006","article-title":"Varicella zoster vaccines and their implications for development of HSV vaccines","volume":"435","author":"Gershon","year":"2013","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.jiac.2025.102713_bib4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jiac.2025.102713_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102713_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.21775\/cimb.041.469","article-title":"Alphaherpesvirus vaccines","volume":"41","author":"Aschner","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jiac.2025.102713_bib8","series-title":"Recombinant zoster vaccine in immunocompetent and immunocompromised adults: a review of clinical studies. Vol. 19, Human Vaccines and Immunotherapeutics","author":"Mwakingwe-Omari","year":"2023"},{"issue":"15","key":"10.1016\/j.jiac.2025.102713_bib9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jiac.2025.102713_bib10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an ASO1 -adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults \u226550 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"JID (J Infect Dis)"},{"issue":"8","key":"10.1016\/j.jiac.2025.102713_bib11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"JID (J Infect Dis)"},{"issue":"4","key":"10.1016\/j.jiac.2025.102713_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jiac.2025.102713_bib13","first-page":"412","article-title":"Autoimmune encephalitis: clinical spectrum and management","volume":"vol. 21","author":"Uy","year":"2021"},{"issue":"1","key":"10.1016\/j.jiac.2025.102713_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/0004-282x20170176","article-title":"Autoimmune encephalitis: a review of diagnosis and treatment","volume":"76","author":"Dutra","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jiac.2025.102713_bib15","first-page":"1505","article-title":"Neurological sequelae of vaccines","volume":"vol. 44","author":"McAlpine","year":"2023"},{"key":"10.1016\/j.jiac.2025.102713_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.940780","article-title":"Anti-NMDA receptor encephalitis and vaccination: a disproportionality analysis","volume":"13","author":"Martin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2025.102713_bib17","article-title":"Case report: anti-GAD65 antibody-associated autoimmune encephalitis following HPV vaccination","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol"},{"issue":"Meeting Abstracts 1","key":"10.1016\/j.jiac.2025.102713_bib18","article-title":"Encephalitis after vaccination in United States. A report from the CDC\/FDA vaccine adverse event reporting system. [1990-2010] (P03.151)","volume":"78","author":"Al Qudah","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jiac.2025.102713_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/acn3.51659","article-title":"Postvaccinal GABA-B receptor antibody encephalitis after ChAdOx1 nCoV-19 vaccination","volume":"9","author":"Ahn","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102713_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/a-2212-6936","article-title":"Anti-NMDA autoimmune encephalitis post-COVID-19 vaccination in a pediatric patient: a case report","volume":"55","author":"Alabssi","year":"2024","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.jiac.2025.102713_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.26182","article-title":"Postvaccinal encephalitis after ChAdOx1 nCov-19","volume":"90","author":"Zuhorn","year":"2021","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102713_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jiac.2025.102713_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2025.102713_bib24","first-page":"57A","article-title":"Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's","volume":"11","author":"Tyler","year":"2004","journal-title":"Herpes"},{"issue":"1","key":"10.1016\/j.jiac.2025.102713_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/01.wnl.0000191407.81333.00","article-title":"Etiology of aseptic meningitis and encephalitis in an adult population","volume":"66","author":"Kupila","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jiac.2025.102713_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/archdischild-2011-300100","article-title":"Encephalitis in children","volume":"97","author":"Thompson","year":"2012","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.jiac.2025.102713_bib27","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/brain\/awac166","article-title":"Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes","volume":"145","author":"Lee","year":"2022","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jiac.2025.102713_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jiac.2025.102713_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmrv.2023.150767","article-title":"Therapeutic plasma exchange versus FcRn inhibition in autoimmune disease","volume":"38","author":"Mina-Osorio","year":"2024","journal-title":"Transfus Med Rev"},{"issue":"9","key":"10.1016\/j.jiac.2025.102713_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","article-title":"Treatment options in refractory autoimmune encephalitis","volume":"36","author":"Dinoto","year":"2022","journal-title":"CNS Drugs"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:17:10Z","timestamp":1748517430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1341321X25001102"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102713","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-vaccinal seronegative autoimmune encephalitis following recombinant zoster vaccination in two immunocompetent patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102713"}}